| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.04B | -9.8% |
| R&D Expense | $39.3M | +80.2% |
| SG&A Expense | $245.1M | +10.9% |
| Operating Income | -$3.70B | -86.8% |
| Pre-tax Income | -$4.38B | -62.6% |
| Income Tax | -$26.8M | -111.3% |
| Net Income | -$2.85B | -77.4% |
| EPS (Basic) | -$12.81 | -72.9% |
| EPS (Diluted) | -$12.81 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $170.7M | -0.8% |
| Inventory | $402.1M | -12.5% |
| Current Assets | $1.72B | -8.5% |
| Total Assets | $19.90B | -2.7% |
| Current Liabilities | $1.33B | -10.3% |
| Long-term Debt | $12.90B | +20.9% |
| Total Liabilities | $15.73B | +16.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$766.2M | +6.7% |
| Capital Expenditures | $1.6M | -92.5% |
| Investing Cash Flow | -$2.70B | -3.4% |
| Financing Cash Flow | $3.43B | -1.2% |
| Free Cash Flow | -$767.7M | +8.8% |
| -72.9% |
| Stockholders' Equity |
| $2.55B |
| -51.2% |